People · Operator
Named in public records as an officer, director or promoter · active 2010–2021 · Biotechnology, Other Health Care, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Avalo Therapeutics, Inc. | — | Biotechnology | Series D+ | $181.8M | $1.6B | 2013 |
| Dermira, Inc. | — | Other Health Care | Series C | $113.0M | $22.9M | 2014 |
| Dr. Tattoff, Inc. | — | Other Health Care | Seed | $11.3M | $12.0M | 2010 |
| Applied UV, Inc. | — | Other Health Care | Series A | $7.1M | $115.5M | 2021 |
| First Wave Technologies, Inc. | — | Other Technology | Seed | $2.7M | $13.5M | 2012 |
| Medisync Bioservices Inc | — | Other Health Care | Pre-Seed | $625K | $19.3M | 2010 |
| First Wave Products Group, LLC | — | Other Technology | Pre-Seed | $130K | $5.5M | 2011 |
EUGENE A. BAUER at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside EUGENE A. BAUER on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gene E. Burleson | 4 | 5 |
| Eugene Bauer | 2 | 3 |
| Alastair J Clemow | 2 | 2 |
| Wayne R. Hellman | 2 | 2 |
| Joel E Kanter | 2 | 2 |
| Brian D Bell | 2 | 2 |
| Alfred D Culliton | 2 | 2 |
| R. Dean E Hautamaki | 2 | 2 |
| Joel D Kanter | 2 | 2 |
| Wende Hutton | 1 | 16 |
| Isaac Blech | 1 | 14 |
| Aaron Kantoff | 1 | 6 |
| Sol J. Barer | 1 | 6 |
| Jake Nunn | 1 | 5 |
| Phil Gutry | 1 | 4 |
| David E. Cohen | 1 | 4 |
| Jake R. Nunn | 1 | 4 |
| Frank A. Torti | 1 | 3 |
| Thomas Wiggans | 1 | 3 |
| Keith A. Blakely | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.